Fraction Analysis of Cysteine‑Linked Antibody-Drug Conjugates Using Hydrophobic Interaction Chromatography

Applications | 2017 | Agilent TechnologiesInstrumentation
HPLC
Industries
Clinical Research
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Analysis of Cysteine-Linked Antibody Drug Conjugates
Analysis of Cysteine-Linked Antibody Drug Conjugates
2017|Agilent Technologies|Applications
Convenient and Reliable Analysis of Antibody Drug Conjugates
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications
High Salt—High Reproducibility - Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System